Which institutional investors increased RGC holdings after its 4,726% price surge by August 2025?

Regencell Bioscience Holdings Limited (US:RGC) experienced a notable increase in institutional interest following its significant price surge of 4,726% by August 2025. As of the most recent reporting period (Q2 2025), the number of institutional owners holding RGC shares doubled, showing a 100% quarter-over-quarter increase in institutional owners. Furthermore, the average portfolio allocation to RGC by these institutions saw a substantial rise of 34,146.54% quarter-over-quarter.

While specific individual increases for each investor require detailed 13F filing analysis, the Fintel platform identifies the following as prominent institutional owners and shareholders of RGC:

• Y-Intercept (Hong Kong) Ltd
• Greenfield Savings Bank
• Geode Capital Management, Llc
• FNCMX - Fidelity Nasdaq Composite Index Fund
• Royal Bank Of Canada
• Tower Research Capital LLC (TRC)
• BlackRock, Inc.
• Farther Finance Advisors, LLC
• Morgan Stanley

These institutions collectively held 39,738 shares, indicating a growing institutional presence in RGC after its significant market performance.